Positive Technology Journal

 Via Medgadget

Cyberkinetics Neurotechnology Systems Inc. is currently focused on the commercialization of two proprietary platforms for neural stimulation, neural sensing in the brain and real-time neural signal decoding technology. These unique and powerful platforms can restore sensation, communication, limb movement as well as other bodily functions.

 

The BrainGate™ Neural Interface System is currently the subject of a pilot clinical trial being conducted under an Investigational Device Exemption (IDE) from the FDA. The system is designed to restore functionality for a limited, immobile group of severely motor-impaired individuals. It is expected that people using the BrainGate™ System will employ a personal computer as the gateway to a range of self-directed activities. These activities may extend beyond typical computer functions (e.g., communication) to include the control of objects in the environment such as a telephone, a television and lights...

 

The NeuroPort™ System is an FDA cleared medical device intended for temporary (< 30 days) recording and monitoring of brain electrical activity.

 

The NeuroPort™ System is based on Cyberkinetics' BrainGate™technology and consists of two parts, the NeuroPort™ Cortical Microelectrode Array (NeuroPort™ Array) and the NeuroPort™ Neural Signal Processor (NeuroPort™ NSP). The NeuroPort™ Array senses action potentials from individual neurons in the brain. The NeuroPort™ NSP records these high resolution signals and provides a physician with the tools to analyze them...